Lexicon Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Lexicon Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Lexicon Pharmaceuticals Inc
Rating: 1.50250
Author: Trendlyne DVM scores

about

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered...

2.04 -0.01 (-0.49%)

85.45% Gain from 52W Low

2.5M

XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

10.0 / 100

Technically Neutral

50.1 / 100

1Yr Price target upside is 89%

5 analysts

Lexicon Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lexicon Pharma Inc Live Stock Price Today, Share Analysis and Chart

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered...

85.45% Gain from 52W Low

SWOT Analysis

Lexicon Pharma Inc Live Price Chart

Lexicon Pharma Inc Live Price Chart